Follow
Jonathan Hazlehurst
Jonathan Hazlehurst
ACL University of Birmingham
Verified email at bham.ac.uk
Title
Cited by
Cited by
Year
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ...
The Lancet 387 (10019), 679-690, 2016
15182016
Non-alcoholic fatty liver disease and diabetes
JM Hazlehurst, C Woods, T Marjot, JF Cobbold, JW Tomlinson
Metabolism 65 (8), 1096-1108, 2016
4782016
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
MJ Armstrong, D Hull, K Guo, D Barton, JM Hazlehurst, LL Gathercole, ...
Journal of hepatology 64 (2), 399-408, 2016
3522016
Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort
MZ Cader, A Filer, J Hazlehurst, P De Pablo, CD Buckley, K Raza
Annals of the rheumatic diseases 70 (6), 949-955, 2011
2062011
Mechanisms in endocrinology: Non-alcoholic fatty liver disease in common endocrine disorders
JM Hazlehurst, JW Tomlinson
European Journal of Endocrinology 169 (2), R27-R37, 2013
912013
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non‐alcoholic steatohepatitis
MJ Armstrong, JM Hazlehurst, D Hull, K Guo, S Borrows, J Yu, SC Gough, ...
Diabetes, Obesity and Metabolism 16 (7), 651-660, 2014
702014
Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo
JM Hazlehurst, LL Gathercole, M Nasiri, MJ Armstrong, S Borrows, J Yu, ...
The Journal of Clinical Endocrinology & Metabolism 98 (4), 1631-1640, 2013
702013
Dual-5α-reductase inhibition promotes hepatic lipid accumulation in man
JM Hazlehurst, AI Oprescu, N Nikolaou, R Di Guida, AEK Grinbergs, ...
The Journal of Clinical Endocrinology & Metabolism 101 (1), 103-113, 2016
642016
Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management
MJ Armstrong, JM Hazlehurst, R Parker, E Koushiappi, J Mann, S Khan, ...
QJM: An International Journal of Medicine 107 (1), 33-41, 2014
552014
The endocrine and metabolic characteristics of a large Bardet-Biedl syndrome clinic population
S Mujahid, KF Hunt, YS Cheah, E Forsythe, JM Hazlehurst, K Sparks, ...
The Journal of Clinical Endocrinology & Metabolism 103 (5), 1834-1841, 2018
522018
Prevalence and severity of non‐alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching …
T Marjot, E Sbardella, A Moolla, JM Hazlehurst, GD Tan, M Ainsworth, ...
Diabetic Medicine 35 (1), 89-98, 2018
432018
Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice
MJ Armstrong, C Corbett, J Hodson, N Marwah, R Parker, DD Houlihan, ...
Postgraduate medical journal 89 (1058), 685-692, 2013
392013
A comparative quality assessment of evidence‐based clinical guidelines in endocrinology
JM Hazlehurst, MJ Armstrong, M Sherlock, IA Rowe, MW O'Reilly, ...
Clinical endocrinology 78 (2), 183-190, 2013
392013
Advanced non‐alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alström syndrome
LL Gathercole, JM Hazlehurst, MJ Armstrong, R Crowley, S Boocock, ...
Liver International 36 (11), 1704-1712, 2016
272016
Developing integrated clinical pathways for the management of clinically severe adult obesity: a critique of NHS England policy
JM Hazlehurst, J Logue, HM Parretti, S Abbott, A Brown, DJ Pournaras, ...
Current obesity reports 9, 530-543, 2020
212020
Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure
TR Lim, JM Hazlehurst, AI Oprescu, MJ Armstrong, SF Abdullah, ...
Clinical endocrinology 90 (3), 440-448, 2019
212019
SFRP2 is associated with increased adiposity and VEGF expression
RK Crowley, MW O’Reilly, IJ Bujalska, ZK Hassan-Smith, JM Hazlehurst, ...
PLoS One 11 (9), e0163777, 2016
212016
team Lt, Abouda G, Aldersley MA, Stocken D, Gough SC, Tomlinson JW, Brown RM, Hubscher SG, Newsome PN. Liraglutide safety and efficacy in patients with non-alcoholic …
MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ...
Lancet 387 (10019), 679-90, 2016
182016
Compliance with established guidelines for the radiological reporting of atypical femoral fractures
K Harborne, JM Hazlehurst, H Shanmugaratnam, S Pearson, A Doyle, ...
The British journal of radiology 89 (1057), 20150443, 2016
132016
Prognostic models for predicting remission of diabetes following bariatric surgery: a systematic review and meta-analysis
P Singh, NJ Adderley, J Hazlehurst, M Price, AA Tahrani, ...
Diabetes care 44 (11), 2626-2641, 2021
112021
The system can't perform the operation now. Try again later.
Articles 1–20